Hemp & HealthWAR:HMP -9.76%32 PS Ratio is 111.00 as of Jul. 05, 2026, which is 936% above its 10-year median of 10.71. GuruFocus rates WAR:HMP with a GF Score™ of 32/100 and a GF Value™ of zł0.32 (Fairly Valued). The stock has 4 warning signs investors should review. Among 949 Drug Manufacturers companies, Hemp & Health ranks worse than 98% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Hemp & Health's share price is zł0.333.
Hemp & Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł0.00. Hence, Hemp & Health's PS Ratio for today is 111.00.
The historical rank and industry rank for Hemp & Health's PS Ratio or its related term are showing as below:
WAR:HMP'
s PS Ratio Range Over the Past 10 Years
Min: 0.99 Med: 10.71 Max: 545
Current: 111
During the past 13 years, Hemp & Health's highest PS Ratio was 545.00. The lowest was 0.99. And the median was 10.71.
WAR:HMP's PS Ratio is ranked worse than 98% of 949
companies
in the Drug Manufacturers industry
Industry Median: 2.31
vs WAR:HMP: 111.00
Hemp & Health SA revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Hemp & Health was 200.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -41.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -31.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -31.40% per year.
During the past 13 years, Hemp & Health's highest 3-Year average Revenue per Share Growth Rate was 101.00% per year. The lowest was -68.70% per year. And the median was -38.70% per year.
Back to Basics: PS Ratio
Hemp & Health (WAR:HMP) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Hemp & Health PS Ratio Related Terms
Hemp & Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Hemp & Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hemp & Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemp & Health PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hemp & Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Hemp & Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Hemp & Health's Share Price of today is zł0.333. Hemp & Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Hemp & Health (WAR:HMP) has a PS Ratio of 111.00 as of Jul. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Hemp & Health and its competitors. This is 936% above median its historical median of 10.71. Over the past decade, Hemp & Health's PS Ratio has ranged from 0.99 to 545.00. According to the industry distribution chart, Hemp & Health ranks #930 out of 949 companies in the Drug Manufacturers industry, placing it in the top 98%.
Is Hemp & Health's PS Ratio too high?
Hemp & Health's current PS Ratio of 111.00 is 936% above median its 10-year median of 10.71. Over the past 10 years, this metric has ranged from a low of 0.99 to a high of 545.00. The Drug Manufacturers industry median PS Ratio is 2.31. Hemp & Health's value of 111.00 is 4705.2% above this industry median. Based on the distribution chart, Hemp & Health ranks #930 out of 949 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hemp & Health has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hemp & Health's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hemp & Health ranks #930 out of 949 companies for PS Ratio. This places Hemp & Health in the lower half of its industry. The industry median PS Ratio is 2.31. Hemp & Health's value of 111.00 is 4705.2% above this benchmark. Historically, Hemp & Health's own PS Ratio has ranged from 0.99 to 545.00 over the past decade. While the company's 10-year median is 10.71 vs. the industry median of 2.31, Hemp & Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.31, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hemp & Health's current PS Ratio of 111.00 is 4705.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Hemp & Health and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemp & Health's current PS Ratio is 111.00, which is 936% above median its own 10-year median of 10.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemp & Health stock overvalued right now?
Based on GuruFocus' analysis, Hemp & Health (WAR:HMP) is currently considered Fairly Valued. The stock's GF Value™ is zł0.32, compared to a current price of zł0.33 — trading 4.1% above its estimated fair value. The current PS Ratio is 111.00, which is 936% above median its 10-year median of 10.71 and 4705.2% above the Drug Manufacturers industry median of 2.31. Hemp & Health's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Hemp & Health (WAR:HMP), the current PS Ratio is 111.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hemp & Health (WAR:HMP) Overvalued in 2026?
Based on GuruFocus' analysis, Hemp & Health stock appears to be overvalued.
The current stock price of zł0.33 is trading 4.1% above its estimated GF Value™ of zł0.32.
GuruFocus considers Hemp & Health to be Fairly Valued.
Key valuation signals for WAR:HMP:
PS Ratio: 111.00 (936% above median its 10-year median of 10.71)
GF Value™: zł0.32 vs. price of zł0.33 (4.1% above fair value)
Industry Position: 4705.2% above the Drug Manufacturers median (#930 of 949)
No single metric tells the full story. See the WAR:HMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemp & Health SA is engaged in hemp and cannabis cultivation. The company processes harvested crops such as CBD and CBG, used for the production of white labels and private labels oils, creams, dried herbs and liquids for vaporization.
32GF Score
Get the complete analysis for WAR:HMP
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:HMP has been successfully added to your 
